What is VK2735 used for?
VK2735 is most commonly used for people following the oral-GLP-1 race who want a needle-free option; users tracking next-generation weight-loss compounds before approval; anyone comparing it to Tirzepatide's GLP-1/GIP mechanism. Investigational dual agonist (GLP-1 + GIP) from Viking Therapeutics, with both a weekly injectable and a once-daily oral form in development. Human evidence for VK2735 is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use VK2735 for
- People following the oral-GLP-1 race who want a needle-free option
- Users tracking next-generation weight-loss compounds before approval
- Anyone comparing it to Tirzepatide's GLP-1/GIP mechanism
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on VK2735
Last updated 2026-06-15.